REVASCULARIZATION TRENDS IN PATIENTS WITH DIABETES MELLITUS AND MULTIVESSEL CORONARY ARTERY DISEASE PRESENTING WITH NON-ST ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE NCDR®  by Pandey, Ambarish et al.
A22
JACC March 17, 2015
Volume 65, Issue 10S
Acute Coronary Syndromes
RevasculaRization tRends in patients with diabetes mellitus and multivessel 
coRonaRy aRteRy disease pResenting with non-st elevation myocaRdial inFaRction: 
insights FRom the ncdR®
Oral Contributions
Room 20A
Monday, March 16, 2015, 11:15 a.m.-11:27 a.m.
Session Title: Highlighted Original Research: Acute Coronary Syndromes and the Year in Review
Abstract Category: 3. Acute Coronary Syndromes: Therapy
Presentation Number: 912-06
Authors: Ambarish Pandey, Darren McGuire, James de Lemos, Sandeep Das, Jarett Berry, Emmanouil Brilakis, Subhash Banerjee, Steven 
Marso, Gregory Barsness, DaJuanicia N. Simon, Matthew Roe, Abhinav Goyal, Mikhail Kosiborod, Ezra Amsterdam, Dharam Kumbhani, 
University of Texas Southwestern Medical Center, Dallas, TX, USA, Duke Clinical Research Institute, Durham, NC, USA
background:  Current guidelines recommend CABG over PCI in patients with diabetes mellitus (DM) and multivessel CAD (mvCAD). 
However, the revascularization decision in these patients may differ in the setting of non-ST-elevation myocardial infarction (NSTEMI). We 
sought to study temporal trends in the management of these patients in a large national database.
methods:  Using data from the NCDR-ACTION registry, we compared revascularization strategies in DM patients who presented with 
NSTEMI between 2008 and 2013 and had mvCAD on angiography. All participating centers had on-site PCI/CABG. Logistic multivariate 
regression models were constructed to identify factors associated with undergoing PCI vs. CABG.
Results:  We included 22,817 DM patients from 489 hospitals (46% received in-hospital PCI, 36% received in-hospital CABG). The use of 
overall revascularization increased over the study duration with an increase in the proportional use of PCI (Ptrend=0.002) and no change 
in the use of CABG (Ptrend=0.55) (Figure). There was significant variability among hospitals in the use of CABG (range: 12%-67%) vs. PCI 
(range: 16%-80%) (p<0.0001) for DM patients. Important patient-level, but not hospital-level, characteristics were strongly associated with 
the use of PCI vs. CABG including older age, female sex, and history of heart failure.
conclusion:  Only 1/3rd of DM patients with NSTEMI and mvCAD on angiography undergo CABG with a proportional and temporal 
increase in the use of PCI in contemporary practice.
 
